Bioperfectus, a leading molecular diagnostic supplier in the global market has formed strategic alliance with Emergo by UL, a pioneering regulatory consulting firm specialized in global medical device and IVD compliance. The partnership will significantly improve the efficiency of regulatory and registration process and greatly shorten the time of market access for Bioperfectus products in 180+ countries around the globe.

After successfully entering into the capital market at the end of 2019, Bioperfectus decided to start a new era of global development.  Through the close cooperation with international regulatory and compliance agency, Bioperfectus has taken a step further to expand its global reach.

In the near future, Bioperfectus will continue to advance the knowledge in specific local IVD market and make greater contribution to a healthier life for the mankind.